• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD EVOLUTION® COLONIC CONTROLLED-RELEASE STENT - UNCOVERED; MQR STENT, COLONIC METALLIC EXPANDABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD EVOLUTION® COLONIC CONTROLLED-RELEASE STENT - UNCOVERED; MQR STENT, COLONIC METALLIC EXPANDABLE Back to Search Results
Catalog Number UNKNOWN
Device Problems Off-Label Use (1494); Improper or Incorrect Procedure or Method (2017)
Patient Problems No Consequences Or Impact To Patient (2199); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/05/2020
Event Type  malfunction  
Event Description
Zhou-2020 (evo-c): safety and efficacy of through-the-scope placement of colonic self-expandable metal stents without fluoroscopic guidance: a retrospective cohort study.Retrospective study carried out in patients undergoing endoscopic sems insertion with or without fluoroscopic guidance for malignant large-bowel obstruction in a single tertiary medical center.Sems placement was performed using a 1-channel endoscope with working channel = 3.7 mm diameter (cf-h260; olympus co., tokyo, japan).The stenting procedures are briefly summarized as follows: in the f group, a hydrophilic guidewire and a biliary dilation catheter (cook medical, winston-salem, nc) were inserted through the stricture.Then, the guidewire was removed and a water-soluble contrast agent was injected through catheter to insure proper entry into the proximal lumen and to evaluate the length of the stenosis under fluoroscopy.Then, after the guidewire was reinserted and the dilation catheter was withdrawn, the stent was advanced through the endoscope across the lesion and deployed under endoscopic and fluoroscopic guidance.In the nf group, procedures were otherwise the same as in f group, except that fluoroscopy was not used and contrast agent injection was omitted (off-label use).Guidewire and dilation catheter were considered across the stricture when they were easily advanced without resistance.When resistance was felt, the guidewire tip direction was adjusted.Insertion was retried until easy advance of at least 10 cm of both the guidewire and the catheter.The stent was deployed only under endoscopic monitoring.Stent length must allow for at least 2 cm of additional exposure to each end of the stricture.If one stent was not long enough to cover the obstruction, a second stent was used and at least 3 cm of overlap was obtained.In 56 patients, stents were placed without fluoroscopic guidance (off-label).
 
Manufacturer Narrative
510(k) number: k163468 the investigation is still pending, a follow up mdr will be submitted to include the investigation conclusions.
 
Manufacturer Narrative
510(k) number: k163468 device evaluation: the evolution colonic devices of unknown lot number involved in this complaint were not available for evaluation.With the information provided, a document based investigation was conducted.This file was created from the attached journal article to capture ¿zhou-2020 (evo-c): safety and efficacy of through-the-scope placement of colonic self-expandable metal stents without fluoroscopic guidance: a retrospective cohort study.Additional complaint files (b)(4) were opened as a result of this paper.Reference "zhou-2020.Pdf".Document review including ifu review: as the evolution colonic devices are from unknown lot number, a review of the relevant manufacturing records cannot be conducted.Prior to distribution, all evolution colonic devices are subjected to functional checks and visual inspection to ensure device integrity.These inspections and functional checks are outlined in internal procedures in place at cirl.The notes section of the instructions for use, ifu0052-11, which accompanies this device instructs the user "stent should be placed endoscopically with fluoroscopic monitoring ¿ there is evidence to suggest that the customer did not follow the instructions for use.Root cause review: a definitive root cause could be determined from the available information.From the journal article it is known that the user used the device off-label, stents were placed without fluoroscopic guidance which is off label as per ifu.Summary: complaint is confirmed based on the customer's testimony.No patient death was reported.Complaints of this nature will continue to be monitored for potential emerging trends.
 
Event Description
Supplemental report is being submitted due to the completion of the investigation.
 
Manufacturer Narrative
Pma/510(k) # k163468.Device evaluation: the evolution colonic devices of unknown lot number involved in this complaint were not available for evaluation.With the information provided, a document based investigation was conducted.This file was created from the attached journal article to capture ¿zhou-2020 (evo-c): safety and efficacy of through-the-scope placement of colonic self-expandable metal stents without fluoroscopic guidance: a retrospective cohort study.Additional complaint files (b)(4)were opened as a result of this paper.Reference (b)(4).Lab evaluation: n/a.Document review including ifu review: as the evolution colonic devices are from unknown lot number, a review of the relevant manufacturing records cannot be conducted.Prior to distribution, all evolution colonic devices are subjected to functional checks and visual inspection to ensure device integrity.These inspections and functional checks are outlined in internal procedures in place at cirl.The notes section of the instructions for use which accompanies this device instructs the user "stent should be placed endoscopically with fluoroscopic monitoring ¿ there is evidence to suggest that the customer did not follow the instructions for use.Image review: n/a.Root cause review: a definitive root cause of user error could be determined from the available information.From the journal article it is known that the user has not complied with the requirements of the ifu and/label.According to the information available the customer placed the stents without the use of fluoroscopic guidance.Summary: complaint is confirmed based on the customer's testimony.No patient death was reported.Complaints of this nature will continue to be monitored for potential emerging trends.
 
Event Description
Supplemental follow-up report is being submitted due to correction and updating the file as follows: annex a 'medical device problem code' was updated from code a2304-off-label use to code a2303- improper or incorrect procedure or method and annex g 'component' code was updated from code g04122 (g04122- stent ) to g07001 (g07001- part/component/sub-assembly term not applicable).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLUTION® COLONIC CONTROLLED-RELEASE STENT - UNCOVERED
Type of Device
MQR STENT, COLONIC METALLIC EXPANDABLE
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
Manufacturer (Section G)
COOK IRELAND LTD
o halloran road
national technology park
limerick
Manufacturer Contact
sinead o'leary
o halloran road
national technology park
limerick 
MDR Report Key11345320
MDR Text Key280449564
Report Number3001845648-2021-00132
Device Sequence Number1
Product Code MQR
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 12/06/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date10/05/2020
Event Location Hospital
Initial Date Manufacturer Received 01/22/2021
Initial Date FDA Received02/18/2021
Supplement Dates Manufacturer Received01/22/2021
01/22/2021
Supplement Dates FDA Received07/07/2021
01/03/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age71 YR
Patient SexMale
-
-